PON1 levels in the blood and genotype-related catalytic activity have a major impact on an individual’s susceptibility to OPs (pollutants and insecticides), development of atherosclerosis and drug metabolism [16,18,25]. This evidence concerns the gene PON1 and atherosclerosis.